Evonik Industries (FRA:EVK) received a €31.30 ($36.40) price target from investment analysts at Credit Suisse Group in a report released on Wednesday. The brokerage currently has a “buy” rating on the stock. Credit Suisse Group’s price target points to a potential upside of 13.69% from the stock’s current price.
EVK has been the subject of a number of other research reports. Morgan Stanley set a €38.00 ($44.19) target price on Evonik Industries and gave the company a “buy” rating in a report on Tuesday, July 24th. Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a “buy” rating in a report on Tuesday, October 2nd. UBS Group set a €27.00 ($31.40) target price on Evonik Industries and gave the company a “sell” rating in a report on Monday, July 16th. Commerzbank set a €39.00 ($45.35) price target on Evonik Industries and gave the stock a “buy” rating in a research note on Monday, September 17th. Finally, Independent Research set a €34.00 ($39.53) price target on Evonik Industries and gave the stock a “neutral” rating in a research note on Tuesday, August 7th. Five investment analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of €34.48 ($40.09).
Evonik Industries stock traded up €0.48 ($0.56) during midday trading on Wednesday, reaching €27.53 ($32.01). The company’s stock had a trading volume of 904,127 shares. Evonik Industries has a fifty-two week low of €26.78 ($31.14) and a fifty-two week high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: Bear Market
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.